Responses
Clinical and epidemiological research
Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor α antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study
Compose a Response to This Article
Other responses
No responses have been published for this article.